Subject: Cancer Prevention and Research Institute of Texas (CPRIT) and Emerging Technology Fund (ETF) Briefing
Date: September 28, 2009
Time: 1:00 - 4:00 pm
CPRIT: 1:00 - 2:30 pm
ETF: 2:30 - 4:00 pm
Location: Amphitheater, Texas A&M Institute for Preclinical Studies
800 Stotzer Parkway, Bldg. 1904, 979-847-8477
Parking: Behind the building (map included)
Leadership from the Cancer Prevention and Research Institute of Texas (CPRIT) and the Emerging Technology Fund (ETF) will be on campus Monday, September 28, to provide information updates about these programs. Attending will be:
Alan Kirchhoff - Director of the Emerging Technology Fund
David Nance - Executive Director, Innovate Texas Foundation
Ryan Confer - Director of Operations, Innovate Texas Foundation
Bob Pearson - Chairman of ETF Advisory Committee
Dr. William (Bill) Gimson, Executive Director, CPRIT
Dr. Alfred (Al) Gilman, Chief Scientific Officer of CPRIT
Dr. Rebecca (Becky) Garcia, Chief Prevention Officer, CPRIT
Ms. Heidi McConnell, Office of the Governor
You are invited to attend the briefing and meet key CPRIT/ETF staff members and learn how to apply for CPRIT and ETF funding. Breakout rooms will be available for you to meet one-on-one with both CPRIT and ETF staff regarding your specific research interests.
Teleconferencing capabilities will be available at all campuses for those who are unable to attend the briefing. You will receive information listing the remote TTVN locations shortly.
CPRIT is the Texas initiative to spend $3B over 10 years on cancer research. Al Gilman, the CSO of CPRIT, is a Nobel prize winner from UT Southwestern who described what they want to do to Science earlier this year (pdf at the CPRIT site)
Q: Is there going to be any attempt at geographic diversity?What's the point of having an Aggie governor if politics can't steer CPRIT money to A&M? Vision 1920 is confident that the ETF folks know who where their loyalties belong.
A.G.: Not much. (Laughs.) I’ve said a pretty consistent line here that I’m going to take the politics out of this.
But if you look at the data, roughly half of NCI [National Cancer Institute]funding in Texas goes to M. D. Anderson [Cancer Center]. All of the UT components account for about 75% of NCI funding in the state. Now add Baylor [College of Medicine], and you are at about 90%. So that’s not evenly distributed geographically. It’s based on peer review. And so I think it will shake out roughly that way.According to the NIH reporting tool, there are 1,406 NCI awards to Texas. 22 of them are listed as being in the 17th Congressional district, which includes A&M. Of these, 2 are to Lynntech, a local company. That's about 1.5% for A&M. If even if we only get that share of the CPRIT funding, it works out to about $4.5 million per year.
But I think the high-risk, high-impact program will provide opportunities for people in smaller schools to compete. A great idea can come from anyplace.Smaller schools?!!
Vision 1920 is confident that Dr. Gilman will be impressed by the kinds of great ideas for biotech we embrace here at TAMU. After all, David Nance, who is on the ETF part of the event, was one of the founders of Introgen, a company we were ready to partner with.